Genomic Alterations and Targeted Treatment by Race in Metastatic Breast Cancer Emily Podany, MD, Hematology-Oncology Fellowship Program, Fellow Wellness Leader, WashU Division of Oncology, was recently spotlighted in JNCCN360 for her work on Genomic Alterations and Targeted Treatment by Race in Metastatic Breast Cancer. The study used a multi-institution consortium database that includes both clinical […]
Congratulations to Division Chief of General Medicine & Geriatrics, Dr. Bradley Evanoff, on his journalistic publication.
Kudos to everyone who helped make the 2nd Annual Glomerular Disease Symposium: An Update on Disease Mechanisms and Management, held September 6 – 7, 2024, a success. The event was organized and chaired by WashU Nephrology’s Tingting Li, MD, MSCI, with the support of the planning committee members Michelle Bloom, BSN, RN, Reena Gurung, MD, Nidia Messias, MD, and Morgan Schoer, MD, and Continuing Medical […]
Crucial intersection of oncology and HIV research, with insights for clinical practice Thomas A. Odeny, MD, MPH, PhD, Assistant Professor of Medicine at WashU Division of Medical Oncology, leads the Global Oncology Initiative. He recently was published in Science Direct with new insights into HIV and cancer research. Dr. Odeny’s research focuses on applying implementation […]
Giulia Petrone, MD, WashU Hematology/Oncology Fellow, study, “Clinical and Therapeutic Implications of Clonal Hematopoisis” was recently published in Annual Review of Genomics and Human Genetics, Volume 25, 2024. Clonal Hematopoiesis (CH) is a condition in which hematopoietic stem and progenitor cells acquire the same somatic mutations, leading to the expansion of these mutated cells. The […]
The Rural Cardiovascular Health Initiative (RCHI) is a collaboration between the American College of Cardiology and the JF Maddox Foundation, to improve cardiovascular outcomes in the rural communities of New Mexico.
Over 80% of patients achieved control within a month, sustained at six months A new study, that Mark Huffman, MD, MPH, William Bowen Professor of Medicine, Co-Director, Global Health Center, WashU Cardiovascular Division, who is a co-author, shows that a treatment plan containing low doses of three antihypertensive drugs in a single pill – known […]
In March, Alexander M. Markov, MD; Sina Jasim, MD, MPH; and Jennifer Powers Carson, PhD had their article titled “A Puzzling Case of Elevated Parathyroid Hormone,” published by The Journal of Applied Laboratory Medicine.
Having a severe case of Covid-19 appears to be linked with an increased risk of subsequent mental illness, including depression and anxiety disorders, and a new study finds that the association is strongest among people who were not vaccinated against the disease.
The Ferraro Lab led by Francesca Ferraro, MD, PhD, Assistant Professor of Medicine, WashU Division of Oncology has recently made significant contribution in understanding the role of MYC mutations in the development of Acute Myeloid Leukemia (AML). Dr. Ferraro’s lab publication, titled “Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote Leukemogenesis,” is […]
Assistant Professor of Medicine Dr. Ali Javaheri was featured in an article titled “Translating metabolic and cardiovascular research into effective treatments: What’s next?” In a special 50th Anniversary edition of the journal Cell.
Healthcare innovation is accelerating at an unprecedented pace, and cardiology is on the brink of transformative change using new forms of remote monitoring and artificial intelligence (AI).
Researchers at Washington University School of Medicine in St. Louis have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer. Only 5% of patients survive five years after diagnosis with the most aggressive brain cancers.
Raja Dandamudi, MD, an assistant professor of pediatrics, Vikas Dharnidharka, MD, a professor of pediatrics, and Tarek Alhamad, MD, a professor of medicine at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection. The international team found that DNA shed from dying […]
Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells — cells that have stopped dividing and drive inflammation — may play important roles in suppressing the immune system and allowing such tumors to grow unchecked.
The Society of Hospital Medicine has several publications, including their monthly newsletter, ‘The Hospitalist.’ For the month of August 2024, Dr. Mark Williams was featured on the cover of the newsletter, and was interviewed for an article titled, “Managing the Long-term Physical Effects of Being a Hospitalist.”
Study in hamsters indicates vaccines targeting nose, mouth may be key to controlling spread of respiratory infections
Marlie Maestas, a fifth-year graduate student in the Millman Lab, recently published her first first-authorship in Nature Communications. The study, titled Identification of unique cell type responses in pancreatic islets to stress, detailed the responses of different pancreatic islet cell types to endoplasmic reticulum and inflammatory stress.
Anuja Java, MD, Associate Professor of Medicine, Director, Kidney Transplant John Cochran VA Medical Center, Division of Nephrology, Washington University School of Medicine recently had two articles published in Science Direct. Thrombotic Microangiopathies and the Kidney Both articles delve into defining current understanding of the pathophysiological mechanisms underlying Thrombotic Microangiopathies (TMAs). TMA is a multisystem […]
Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced productivity of employees and an overall drop in the work force.
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant Hunter Cassidy Cochran, MD, Hematology-Oncology Fellow, was recently published in Leukemia & Lymphoma. In many hematologic malignancies, hematopoietic cell transplant (HCT) is the only curative option. The likelihood of finding […]
DOLF investigators are beginning a follow-up study on the efficacy of a new combination treatment for lymphatic filariasis (LF) and onchocerciasis in the Akoupé district of Côte d’Ivoire. This study began July 4th and builds upon a large-scale community survey sponsored by Medicines Development for Global Health (MDGH).
Researchers in the Department of Medicine reveal new ways that human natural killer (NK) cells are rewired by signals through cytokine receptors to generate a memory-like program. In a report published in Science Immunology, co-first authors Jennifer Foltz, PhD, and Jennifer Tran build on prior work from senior author Todd Fehniger, MD, PhD, WashU Division […]
St. Louis-based center unites scientists, public health experts, nonprofits to fight virus
“Heavy and healthy” can be a rare or common condition. But either way it may signal that some excess weight is just fine.
Associate Professor of Medicine and Associate Director of the Wash U Hypertrophic Cardiomyopathy Center, Dr. Sharon Cresci is Vice-Chair on a new statement published this week in the journal Circulation on behalf of the American Heart Association.
Center will support new collaborations, infrastructure to accelerate precision medicine
“Hexamerization: explaining the original sin of IgG-mediated complement activation in acute lung injury” Hrishikesh S Kulkarni, MD, MSCI, Associate Professor of Medicine and Molecular Microbiology; Associate Program Director for Research, Division of Pulmonary and Critical Care Medicine, recently was published in the Journal of Clinical Investigation (JCI). The editorial in the Journal of Clinical Investigation […]
Congratulations to first-year fellow Susrutha Puthanmadhom Narayanan, MBBS, who presented her research at ASCO 2024 this past weekend entitled, “Transcriptomic Analysis of cAMP/PKA/CREB Signaling in Invasive Lobular Breast Cancer”.
Three dimensional images of human pancreatic islet cells provide an unprecedented view of the enigmatic primary cilia Jing Hughes, MD, Assistant Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research recent paper, “Scanning electron microscopy of human islet cilia” was published in Proceedings of the National Academy of Sciences (PNAS) and follow-up article, “Immuno-scanning […]
Artificial intelligence—the next wave of technology— is emerging in many ways in medical practices and health systems in the St. Louis area.
Genetically engineered B cells could produce super-antibodies to HIV
“Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training” describes the Clinical Trial Development Program initiated at Washington University School of Medicine in 2002. This program was developed as a hands-on learning experience for Hematology-Oncology fellow in the design, implementation and publication of clinical trials and is led by Dr. Lee Ratner, Associate Program Director […]
Study also shows that patients hospitalized within 30 days after infection face 29% higher death risk in 3rd year compared with those not infected
The Hematology/Oncology Fellowship at Washington University School of Medicine is proud to announce that third-year fellow, Stefan Tarnawsky, M.D., Ph.D, has been selected by the American Society of Hematology (ASH) to participate in the 2024 Research Training Award for Fellows (RTAF).
Max Petersen, MD, PhD, Instructor in Medicine, Division of Endocrinology, Metabolism & Lipid Research, recently published a paper, Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity, in Cell Metabolism. The senior author of the study was Samuel Klein, MD, the William Danforth Professor of Medicine, and Chief of the Division of Nutritional Science & […]
Response to updated vaccine is shaped by earlier vaccines yet generates broadly neutralizing antibodies
(interview with Dr. Jeff Millman) Tell Us About Yourself My name is Jeff Millman, PhD, and I am a bioengineer within the Division of Endocrinology, Metabolism and Lipid Research in the Department of Medicine here at WashU. My bioengineering expertise uniquely positions me to pioneer research in a laboratory environment, with a steadfast commitment to […]
This past September, I had the opportunity to participate in an eye-opening event across the river from my hometown of Boston, MA. The event was a discussion of AI in medicine held on the campus of Harvard University. During the discussion, a senior faculty leader at Harvard Medical School commented to the effect that research […]
Leukemia & Lymphoma Society supports trials in cell-based immunotherapies, cancer vaccines
Recently, Fumihiko Urano, MD, PhD joined “It Happened to Me” podcast hosts Cathy Gildenhorn and Beth Glassman to discuss Wolfram syndrome and his ongoing research. Dr. Urano is the director of the Wolfram Syndrome International Registry & Clinical Study and the doctor of Cathy, who has a variant of the disease.
Congratulations to the research group headed by Jeffrey Miner, PhD, on their recent publication that landed the cover of Kidney International. The colorful cover photograph, illustrating paraffin immunofluorescence of different collagen IV chains, is a figure from their article “Quantitative assessment of glomerular basement membrane (GBM) collagen IV α chains in paraffin sections from patients with focal segmental glomerulosclerosis […]
Prostate cancer cellular immunotherapy Russell Pachynski, MD, Associate Professor of Medicine, Division of Oncology, Director of Genitourinary (GU) Oncology Research, Washington University School of Medicine in St. Louis, published a paper in Cancer Immunology Research (“High dimensional analyses reveal activation of lymphocyte subsets and reversal of immunoresistance by cytokine-enhanced cellular vaccine therapy in prostate cancer”) […]
Aditi Ramakrishnan, MD MSc, Assistant Professor in the Division of Infectious Diseases and Department of Medicine at the Washington University in St. Louis School of Medicine, had a first-author publication in Journal of Acquired Immune Deficiency Syndrome (JAIDS), a premier infectious diseases journal, describing the substance use treatment engagement among women with HIV in the […]
On March 5, Jeffrey Millman, PhD was featured on The Sugar Science’s Ask the Expert webinar series, hosted on YouTube. The episode was titled “Unraveling Cellular Complexity in Stem Cell-Derived Islet Identity through Single-Cell Sequencing.”
The Mbalaviele lab and collaborators found that inflammasomes play a critical role in bone loss in mice caused by the chemotherapeutic drug, doxorubicin. This finding may inspire the development of a tailored adjuvant therapy that preserves the quality of this tissue in patients treated with this class of drugs.
The document also strengthens advice regarding which medications should be started in all patients Thomas M. Maddox, MD, MSc, Professor of Medicine in the Cardiovascular Division at WashU Medicine, and colleagues recently published an Expert Consensus Decision Pathway (ECDP) for the many decisions required in the management and treatment of patients with heart failure with […]
“COVID-19 poses a serious risk to brain health, even in mild cases, and the effects are now being revealed at the population level,” clinical epidemiologist Ziyad Al-Aly said
Congratulations to the research team of the Mahjoub Laboratory, who are celebrating their multiple recent publications, one of which landed the cover of the journal JCI Insight.
Members of the Scheller Lab in collaboration with the Milbrandt and DiAntonio groups at WashU published a paper in JCI Insight in which they found that loss of Sarm1 could completely protect female mice against the development of bone loss and severe osteoblast suppression secondary to type 1 diabetes.